Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 636,492 |
|
|||||
| News | - | ||||||
| Day High | 3.49 | Low High |
|||||
| Day Low | 3.11 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acumen Pharmaceuticals Inc | ABOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.11 | -3.17% | 3.36 | 18:43:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.43 | 3.11 | 3.49 | 3.16 | 3.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,256 | 636,492 | $ 3.28 | $ 2,088,009 | - | 1.8101 - 11.3099 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:43:03 | formt | 100 | $ 3.36 | USD |
Acumen Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 183M | 57.91M | - | 0 | -42.86M | -0.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acumen Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.75 | 3.93 | 3.11 | 3.63 | 196,129 | -0.39 | -10.40% |
| 1 Month | 4.23 | 4.43 | 3.11 | 3.91 | 313,972 | -0.87 | -20.57% |
| 3 Months | 3.28 | 5.09 | 2.8949 | 3.82 | 336,789 | 0.08 | 2.44% |
| 6 Months | 3.82 | 5.09 | 1.8101 | 3.19 | 451,307 | -0.46 | -12.04% |
| 1 Year | 3.67 | 11.3099 | 1.8101 | 5.73 | 575,918 | -0.31 | -8.45% |
| 3 Years | 25.07 | 26.98 | 1.8101 | 7.36 | 421,472 | -21.71 | -86.60% |
| 5 Years | 25.07 | 26.98 | 1.8101 | 7.36 | 421,472 | -21.71 | -86.60% |
Acumen Pharmaceuticals Description
| Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers. |
